EMERYVILLE, Calif.,
Jan. 27, 2022 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology
company accelerating the world to sustainable consumption through
its Lab-to-MarketTM operating platform, today announced
the appointment of Ms. Ana Dutra as
its newest independent member of the Amyris Board of Directors,
effective January 21, 2022.
"We are very pleased to welcome Ana as a new, independent
director to Amyris," said John Melo, President and Chief
Executive Officer of Amyris. "Ana brings decades of leadership,
operational depth and highly relevant experience leading
several global acquisitions and post-merger integrations as well as
implementing accelerated growth strategies. We look forward to her
contributions as we continue to execute our strategy and enhance
value for Amyris shareholders."
Ms. Dutra is an experienced CEO, business advisor and corporate
board director of publicly traded, private, and family-owned
corporations, and non-profit organizations. She is a Latina leader
with over 30 years of experience in P&L management, deal
structuring, digital technology, business growth and C-Level
business advisory in over 25 countries. Ana is fluent in English,
French, Spanish, and Portuguese. She has deep experience in ESG,
digital technology, e-commerce, ERP systems and has a CERT
Certification in Cybersecurity Oversight by Carnegie Mellon University and the National
Association of Corporate Directors.
As a CEO, Ana Dutra has led
several global and cross-border acquisitions, joint ventures,
partnership agreements and M&A integrations. In her own tenure
as CEO and P&L leader with companies such as IBM, CSC, Marsh
& McLennan, Accenture and Korn/ Ferry International, Ms. Dutra
created several $500+ million global businesses through the
combination of organic growth, global acquisitions and joint
ventures, innovative go-to-market approaches and incorporation of
technology and digital transformation of services and products.
Ms. Dutra holds an MBA from Kellogg at Northwestern University, a Master's in Economics
from Pontificia Universidade do Rio de
Janeiro, and a Juris Doctor from Universidade do
Rio de Janeiro.
"I am very excited about joining the Amyris Board at this
pivotal time in the company's growth," commented Ms. Dutra. "I look
forward to working with my Board colleagues and the Company's
management team to best leverage the tremendous assets it has
developed to continue to bring diversified and sustainable products
that make a positive impact on people and planet."
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-MarketTM operating platform. This Amyris platform
leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-announces-appointment-of-ana-dutra-to-board-of-directors-301469290.html
SOURCE Amyris, Inc.